Acuity Inc. AYI
337.44 USD +6.18 (+1.87%)
At closeNov 4, 2026, 4:00 PM EST
337.44 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
331.24 Day range 342.81
257.04 52-week range 380.17
- YTD
- -6.28%
- 1 year
- -6.58%
Analyst view
Consensus: buy
Buy
Price target (mean) 370.17 +9.7% upside
Now 337.44
- Target (low)
- 345.00
- Target (mean)
- 370.17
- Target (high)
- 415.00
Ratings (0m) 7 3 buy · 4 hold · 0 sell
- Strong buy2
- Buy1
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.09 | 4.87 – 5.32 | 4.69 | +8.5% | 1.17B | +2.4% | 6 |
| Next quarter | 4.44 | 4.17 – 4.62 | 4.14 | +7.2% | 1.11B | +4.9% | 5 |
| Current year | 21.39 | 21.09 – 21.90 | 19.90 | +7.5% | 4.83B | +4.0% | 6 |
| Next year | 23.34 | 22.98 – 23.75 | 21.39 | +9.1% | 5.07B | +4.9% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 8, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 2, 2026 | Baird | Maintained | Neutral | Neutral |
| Sep 29, 2026 | Baird | Maintained | Neutral | Neutral |
| Sep 28, 2026 | William Blair | Downgrade | Outperform | Market Perform |
| Jul 1, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 26, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jun 26, 2026 | Baird | Maintained | Neutral | Neutral |
| Apr 6, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Apr 6, 2026 | Baird | Maintained | Neutral | Neutral |
| Mar 25, 2026 | Baird | Maintained | Neutral | Neutral |
| Mar 3, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jan 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 2, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 2, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Oct 2, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 2, 2025 | TD Cowen | Maintained | Buy | Buy |
| Oct 2, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 25, 2025 | Baird | Maintained | Neutral | Neutral |
| Sep 2, 2025 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Jun 27, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 27, 2025 | Baird | Maintained | Neutral | Neutral |
| Jun 27, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 18, 2025 | Baird | Maintained | Neutral | Neutral |
| Jun 17, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 4, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 4, 2025 | Baird | Maintained | Neutral | Neutral |
| Mar 28, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Mar 27, 2025 | Baird | Maintained | Neutral | Neutral |
| Jan 9, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
